Choose Exercise Plan Select your exercise strategy
Exenatide, a GLP-1 agonist sold under the brand names Byetta and Bydureon by AstraZeneca (LSE: AZN) as a type 2 diabetes drug, could be useful in another indication, a trial has found
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
LC-MS is particularly valuable for identifying oxidation, deamidation, isomerization, lipid-chain modifications, and peptide truncations, which are common in GLP-1 peptide drugs
For a less expensive, more comprehensive GLP-1 program with long-term support, see our Shed review here
1998 Jul;83(7):2569-72 is fascinating for several reasons